Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The currently used antibiotics may decrease the number of bacteria in biofilms, but they cannot completely eradicate the biofilms”
From Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents—How P. aeruginosa Can Escape Antibiotics (2019) · cites this paper as Fernandez-Barat et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 28
- Emerson, 2002, Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis, Pediatr Pulmonol, 34, 91, 10.1002/ppul.10127 · DOI · Paper page
- Qin, 2012, Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients, Antimicrob Agents Chemother, 56, 5971, 10.1128/AAC.01371-12 · DOI · Paper page
- Frederiksen, 1996, Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment, Pediatr Pulmonol, 21, 153, 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO;2-R · DOI · Paper page
- Giwercman, 1990, Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains, J Antimicrob Chemother, 26, 247, 10.1093/jac/26.2.247 · DOI
- Klockgether, 2013, Intraclonal diversity of the Pseudomonas aeruginosa cystic fibrosis airway isolates TBCF10839 and TBCF121838: distinct signatures of transcriptome, proteome, metabolome, adherence and pathogenicity despite an almost identical genome sequence, Environ Microbiol, 15, 191, 10.1111/j.1462-2920.2012.02842.x · DOI
- Feliziani, 2010, Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections, Plos One, 5, 1932, 10.1371/journal.pone.0012669 · DOI · Paper page
- Oliver, 2000, High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection, Science, 288, 1251, 10.1126/science.288.5469.1251 · DOI · Paper page
- Doring, 2000, Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus, Eur Respir J, 16, 749, 10.1034/j.1399-3003.2000.16d30.x · DOI · Paper page
- Ciofu, 1994, Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center, APMIS, 102, 674, 10.1111/j.1699-0463.1994.tb05219.x · DOI
- Ciofu, 2013, P. aeruginosa in the paranasal sinuses and transplanted lungs have similar adaptive mutations as isolates from chronically infected CF lungs, J Cyst Fibros, 12, 729, 10.1016/j.jcf.2013.02.004 · DOI
- Kragh, 2014, Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients, Infect Immun, 82, 4477, 10.1128/IAI.01969-14 · DOI · Paper page
- Fernandez-Barat, 2012, Direct analysis of bacterial viability in endotracheal tube biofilm from a pig model of methicillin-resistant Staphylococcus aureus pneumonia following antimicrobial therapy, FEMS Immunol Med Microbiol, 65, 309, 10.1111/j.1574-695X.2012.00961.x · DOI
- Pitt, 2003, Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents, Thorax, 58, 794, 10.1136/thorax.58.9.794 · DOI
- Mogayzel, 2013, Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health, Am J Respir Crit Care Med, 187, 680, 10.1164/rccm.201207-1160OE · DOI · Paper page
- Ciofu, 2001, Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, beta-lactamase activity and RiboPrinting, J Antimicrob Chemother, 48, 391, 10.1093/jac/48.3.391 · DOI
- Lebeaux, 2014, Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics, Microbiol Mol Biol Rev, 78, 510, 10.1128/MMBR.00013-14 · DOI · Paper page
- Costerton, 1999, Bacterial biofilms: a common cause of persistent infections, Science, 21, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
- Ciofu, 2005, Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation, Antimicrob Agents Chemother, 49, 2276, 10.1128/AAC.49.6.2276-2282.2005 · DOI · Paper page
- Macia, 2011, Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment, Antimicrob Agents Chemother, 55, 5230, 10.1128/AAC.00617-11 · DOI · Paper page
- Harmer, 2013, Modulation of gene expression by Pseudomonas aeruginosa during chronic infection in the adult cystic fibrosis lung, Microbiology, 159, 2354, 10.1099/mic.0.066985-0 · DOI
- Winstanley, 2016, Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections, Trends Microbiol, 24, 327, 10.1016/j.tim.2016.01.008 · DOI · Paper page
- McCaughey, 2013, Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions, Antimicrob Agents Chemother, 57, 5406, 10.1128/AAC.00750-13 · DOI
- Kolpen, 2010, Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis, Thorax, 65, 57, 10.1136/thx.2009.114512 · DOI · Paper page
- Worlitzsch, 2002, Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients, J Clin Invest, 109, 317, 10.1172/JCI0213870 · DOI · Paper page
- Hoffman, 2009, Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression, J Cyst Fibros, 8, 66, 10.1016/j.jcf.2008.09.006 · DOI · Paper page
- Fothergill, 2010, Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations, J Med Microbiol, 59, 472, 10.1099/jmm.0.015875-0 · DOI
- Clark, 2015, Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis, Sci Rep, 5, 10932, 10.1038/srep10932 · DOI
- Mowat, 2011, Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections, Am J Respir Crit Care Med, 183, 1674, 10.1164/rccm.201009-1430OC · DOI · Paper page
Cited by
Ciofu, O., & Tolker-Nielsen, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00913 · Cited by 842
Self-citationSoares, A., Alexandre, K., & Etienne, M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.02057 · Cited by 113
Metadata
- Authors
- Fernández-Barat, L., Ciofu, O., Kragh, K. N., Pressler, T., Johansen, U., Motos, A., Torres, A., & Hoiby, N.
- Venue
- Journal of Cystic Fibrosis
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 16
- Issue
- 2
- Pages
- 222-229
- ISSN
- 1569-1993
- Cited by
- 50
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 730 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.